BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28566636)

  • 21. Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.
    Feng Y; Wang C; Liu Q; Meng Q; Huo X; Liu Z; Sun P; Yang X; Sun H; Qin J; Liu K
    Eur J Pharm Sci; 2016 Jan; 81():119-28. PubMed ID: 26474691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport.
    El-Sheikh AA; van den Heuvel JJ; Koenderink JB; Russel FG
    J Pharmacol Exp Ther; 2007 Jan; 320(1):229-35. PubMed ID: 17005917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3.
    Chioukh R; Noel-Hudson MS; Ribes S; Fournier N; Becquemont L; Verstuyft C
    Drug Metab Dispos; 2014 Dec; 42(12):2041-8. PubMed ID: 25239859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.
    Vallon V; Eraly SA; Rao SR; Gerasimova M; Rose M; Nagle M; Anzai N; Smith T; Sharma K; Nigam SK; Rieg T
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1293-9. PubMed ID: 22338083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From the Cover: Identification of Natural Products as Inhibitors of Human Organic Anion Transporters (OAT1 and OAT3) and Their Protective Effect on Mercury-Induced Toxicity.
    Wang X; Han L; Li G; Peng W; Gao X; Klaassen CD; Fan G; Zhang Y
    Toxicol Sci; 2018 Feb; 161(2):321-334. PubMed ID: 29045746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters.
    Wong CC; Barron D; Orfila C; Dionisi F; Krajcsi P; Williamson G
    Mol Nutr Food Res; 2011 Jul; 55(7):979-88. PubMed ID: 21538853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The key role of organic anion transporter 3 in the drug-drug interaction between tranilast and methotrexate.
    Wang J; Yuan W; Shen Q; Wu Q; Jiang Z; Wu W; Zhang L; Huang X
    J Biochem Mol Toxicol; 2022 Apr; 36(4):e22983. PubMed ID: 35019195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
    Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ontogeny of expression of organic anion transporters 1 and 3 in ovine fetal and neonatal kidney.
    Wood CE; Cousins R; Zhang D; Keller-Wood M
    Exp Biol Med (Maywood); 2005 Oct; 230(9):668-73. PubMed ID: 16179735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate.
    Elsby R; Fox L; Stresser D; Layton M; Butters C; Sharma P; Smith V; Surry D
    Eur J Pharm Sci; 2011 May; 43(1-2):41-9. PubMed ID: 21440623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
    Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
    Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function.
    Henjakovic M; Hagos Y; Krick W; Burckhardt G; Burckhardt BC
    Am J Physiol Renal Physiol; 2015 Nov; 309(10):F843-51. PubMed ID: 26377792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
    Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
    Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3.
    Zou L; Matsson P; Stecula A; Ngo HX; Zur AA; Giacomini KM
    J Pharm Sci; 2021 Jan; 110(1):347-353. PubMed ID: 32910949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal human organic anion transporter 3 increases the susceptibility of lymphoma cells to bendamustine uptake.
    Hagos Y; Hundertmark P; Shnitsar V; Marada VV; Wulf G; Burckhardt G
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F330-8. PubMed ID: 25477469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human organic anion transporter OAT1 is not responsible for glutathione transport but mediates transport of glutamate derivatives.
    Hagos Y; Burckhardt G; Burckhardt BC
    Am J Physiol Renal Physiol; 2013 Feb; 304(4):F403-9. PubMed ID: 23255614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters.
    Yuan Y; Yang H; Kong L; Li Y; Li P; Zhang H; Ruan J
    Chem Biol Interact; 2017 Nov; 277():79-84. PubMed ID: 28890383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate.
    Liu Q; Wang C; Meng Q; Huo X; Sun H; Peng J; Ma X; Sun P; Liu K
    Pharm Res; 2014 May; 31(5):1120-32. PubMed ID: 24242937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental contaminants modulate transport activity of zebrafish organic anion transporters Oat1 and Oat3.
    Dragojević J; Marić P; Lončar J; Popović M; Mihaljević I; Smital T
    Comp Biochem Physiol C Toxicol Pharmacol; 2020 May; 231():108742. PubMed ID: 32165351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.
    Hsueh CH; Yoshida K; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
    Mol Pharm; 2016 Sep; 13(9):3130-40. PubMed ID: 27467266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.